Skip to main content

Table 3 Associations between risk factors, probing site locations, treatment types, the presence of periodontopathogens and site healing

From: Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial

 

OR (95% CI)

p

Gender (male)

1.31 (0.45–3.84)

0.625

Age

1 (0.94–1.05)

0.893

Smoking

0.39 (0.13–1.20)

0.099

Test group

1.20 (0.44–3.27)

0.719

Molars

0.51 (0.35–0.72)

< 0.001*

Interdental site

0.96 (0.65–1.41)

0.826

Aggregatibacter actinomycetemcomitans

1.68 (0.61–4.63)

0.318

Porphyromonas gingivalis

0.49 (0.17–1.41)

0.184

Prevotella intermedia

0.60 (0.09–4.16)

0.602

Tannerella forsythia

0.80 (0.20–3.15)

0.755

  1. OR odds ratio, CI confidence interval – *, statistically significant change